Julie Yang
7PUBLICATIONS
97CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesis.Vera Tiedje, Pablo Sánchez Vela, Julie L Yang
|Jan 17, 2024
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.Andrew J Dunbar, Robert L Bowman, Young C Park
|Nov 22, 2023
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable.Tamara Codilupi, Jakub Szybinski, Stefanie Arunasalam
|Feb 17, 2023
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis.Andrew J Dunbar, Dongjoo Kim, Min Lu
|Feb 09, 2023
TET2 guards against unchecked BATF3-induced CAR T cell expansion.Nayan Jain, Zeguo Zhao, Judith Feucht
|Jun 19, 2021
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS.A Rose Brannon, Gowtham Jayakumaran, Monica Diosdado
Pageof 2
Frequent Collaborators
3 joint publications
Richard P Koche
3 joint publications
Ross L Levine
3 joint publications
Robert L Bowman
2 joint publications
Tamara Codilupi
2 joint publications
Andrew J Dunbar
2 joint publications
Wenbin Xiao
2 joint publications
Sara C Meyer
2 joint publications
Mirko Farina
1 joint publications
Francesco Marass
1 joint publications
Dana W Y Tsui
